Intravesical chemotherapy In 1996, a pooled meta-analysis of 2,535 patients by the European group EORTC and the Medical Research Council (MRC) found a significant prolongation of the disease-free ...

Credit: J&J. The New Drug Application is supported by data from cohort 2 of the single-arm, phase 2b SunRISe-1 study. The device remains in the bladder and provides a sustained release of gemcitabine ...

Celecoxib Versus Placebo for Men With Prostate Cancer and a Rising Serum Prostate-Specific Antigen After Radical Prostatectomy and/or Radiation Therapy Patients with superficial bladder cancer ...

In recent years the management of non-muscle-invasive bladder cancer has undergone radical changes. Intravesical Bacillus Calmette-Guérin (BCG) has long been established as the therapeutic standard ...

Patients with multiple sclerosis (MS) often have lower urinary tract symptoms, which are usually treated with clean intermittent catheterization and oral antimuscarinic drugs; however, these agents ...

Intravesical therapy is widely used in practice as an adjuvant treatment for early-stage bladder cancer following surgical transurethral resection. This is because it is a localized treatment that is ...

Bladder cancer occurs when cells in the bladder — a water balloon–like organ in the lower abdomen that stores urine — grow out of control. There are many treatment options for bladder cancer, which ...

Inflatable penile prostheses (IPPs) are comprised of two intracorporal cylinders, a scrotal pump and a fluid reservoir. IPP reservoirs come in a variety of sizes and configurations. These reservoirs ...

Gemcitabine delivered via intravesical instillation reduced the risk of recurrence in patients with low-grade non-muscle-invasive urothelial cancer, according to results of a randomized phase III ...

The evidence on the safety of intravesical microwave hyperthermia and chemotherapy for non-muscle-invasive bladder cancer shows there are well-recognised adverse events. Current evidence on its ...

Chemotherapy should be immediate after TUR in patients with non-muscle invasive disease. Bladder cancer is projected to be the fourth most common cancer diagnosed in 2007 and the eighth most common ...